Ricciardelli A, Genet G, Genet N, McClugage 3rd S, Kan P, Hirschi K
Angiogenesis. 2025; 28(2):15.
PMID: 39899215
PMC: 11790818.
DOI: 10.1007/s10456-024-09953-5.
Hermann R, Shovlin C, Kasthuri R, Serra M, Eker O, Bailly S
Nat Rev Dis Primers. 2025; 11(1):1.
PMID: 39788978
DOI: 10.1038/s41572-024-00585-z.
Diwan Z, Kang J, Tsztoo E, Siekmann A
Angiogenesis. 2024; 28(1):5.
PMID: 39656297
PMC: 11632009.
DOI: 10.1007/s10456-024-09955-3.
Schwartze T, Morosky S, Rosato T, Henrickson A, Lin G, Hinck C
bioRxiv. 2024; .
PMID: 39464140
PMC: 11507788.
DOI: 10.1101/2024.10.14.618187.
Yang Y, Wu X, Zhao Y, Zhang D, Zhang L, Cai X
Circulation. 2024; 151(5):299-317.
PMID: 39429196
PMC: 11789604.
DOI: 10.1161/CIRCULATIONAHA.124.070925.
Therapeutic development approaches to treat haploinsufficiency diseases: restoring protein levels.
Evans E, Shyr Z, Traynor B, Zheng W
Drug Discov Today. 2024; 29(12):104201.
PMID: 39384033
PMC: 11649451.
DOI: 10.1016/j.drudis.2024.104201.
A non-genetic model of vascular shunts informs on the cellular mechanisms of formation and resolution of arteriovenous malformations.
Ouarne M, Pena A, Ramalho D, Conchinha N, Costa T, Enjalbert R
Cardiovasc Res. 2024; 120(15):1967-1984.
PMID: 39308243
PMC: 11629978.
DOI: 10.1093/cvr/cvae160.
Somatic mutations in arteriovenous malformations in hereditary hemorrhagic telangiectasia support a bi-allelic two-hit mutation mechanism of pathogenesis.
DeBose-Scarlett E, Ressler A, Gallione C, Sapisochin Cantis G, Friday C, Weinsheimer S
Am J Hum Genet. 2024; 111(10):2283-2298.
PMID: 39299239
PMC: 11480799.
DOI: 10.1016/j.ajhg.2024.08.020.
Pathophysiology in Brain Arteriovenous Malformations: Focus on Endothelial Dysfunctions and Endothelial-to-Mesenchymal Transition.
Jeong J, Bafor A, Freeman B, Chen P, Park E, Kim E
Biomedicines. 2024; 12(8).
PMID: 39200259
PMC: 11351371.
DOI: 10.3390/biomedicines12081795.
Epigenetics enters the stage in vascular malformations.
Abdelilah-Seyfried S
J Clin Invest. 2024; 134(15).
PMID: 39087470
PMC: 11290957.
DOI: 10.1172/JCI182904.
Investigation of the Genetic Determinants of Telangiectasia and Solid Organ Arteriovenous Malformation Formation in Hereditary Hemorrhagic Telangiectasia (HHT).
Whitehead K, Toydemir D, Wooderchak-Donahue W, Oakley G, McRae B, Putnam A
Int J Mol Sci. 2024; 25(14).
PMID: 39062925
PMC: 11276621.
DOI: 10.3390/ijms25147682.
The double whammy of ER-retention and dominant-negative effects in numerous autosomal dominant diseases: significance in disease mechanisms and therapy.
Gariballa N, Mohamed F, Badawi S, Ali B
J Biomed Sci. 2024; 31(1):64.
PMID: 38937821
PMC: 11210014.
DOI: 10.1186/s12929-024-01054-1.
Endothelial-to-Mesenchymal Transition in an Hereditary Hemorrhagic Telangiectasia-like Pediatric Case of Multiple Pulmonary Arteriovenous Malformations.
Lorente-Herraiz L, Cuesta A, Recio-Poveda L, Botella L, Albinana V
Int J Mol Sci. 2024; 25(11).
PMID: 38892351
PMC: 11172626.
DOI: 10.3390/ijms25116163.
Inhibition of endothelial histone deacetylase 2 shifts endothelial-mesenchymal transitions in cerebral arteriovenous malformation models.
Zhao Y, Wu X, Yang Y, Zhang L, Cai X, Chen S
J Clin Invest. 2024; 134(15).
PMID: 38781032
PMC: 11290970.
DOI: 10.1172/JCI176758.
Shear stress and pathophysiological PI3K involvement in vascular malformations.
Abdelilah-Seyfried S, Ola R
J Clin Invest. 2024; 134(10).
PMID: 38747293
PMC: 11093608.
DOI: 10.1172/JCI172843.
Blood flow regulates acvrl1 transcription via ligand-dependent Alk1 activity.
Anzell A, Kunz A, Donovan J, Tran T, Lu X, Young S
Angiogenesis. 2024; 27(3):501-522.
PMID: 38727966
DOI: 10.1007/s10456-024-09924-w.
Phenotypic characterisation of variant carriers.
Caillot C, Saurin J, Hervieu V, Faoucher M, Reversat J, Decullier E
J Med Genet. 2024; 61(8):734-740.
PMID: 38575304
PMC: 11287639.
DOI: 10.1136/jmg-2023-109632.
The ENG/VEGFα Pathway Is Likely Affected by a Nonsense Variant of Endoglin (ENG)/CD105, Causing Hereditary Hemorrhagic Telangiectasia Type 1 (HHT1) in a Chinese Family.
Liu K, Fu J, Guo K, Maghsoudloo M, Cheng J, Fu J
Genes (Basel). 2024; 15(3).
PMID: 38540362
PMC: 10970080.
DOI: 10.3390/genes15030304.
Hereditary hemorrhagic telangiectasia: from signaling insights to therapeutic advances.
Al Tabosh T, Al Tarrass M, Tourvieilhe L, Guilhem A, Dupuis-Girod S, Bailly S
J Clin Invest. 2024; 134(4).
PMID: 38357927
PMC: 10866657.
DOI: 10.1172/JCI176379.
Blood flow regulates transcription via ligand-dependent Alk1 activity.
Anzell A, Kunz A, Donovan J, Tran T, Lu X, Young S
bioRxiv. 2024; .
PMID: 38328175
PMC: 10849739.
DOI: 10.1101/2024.01.25.576046.